"Global U.S. Vaccine Market Overview:
Global U.S. Vaccine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global U.S. Vaccine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of U.S. Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Vaccine Market:
The U.S. Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Vaccine market has been segmented into:
Human Vaccine (Pediatric Vaccines
Adult & Adolescent Vaccines
Other Human Vaccines
By Application, U.S. Vaccine market has been segmented into:
Livestock Vaccines
Companion Animal Vaccines
Other Animal Vaccines
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Vaccine market.
Top Key Players Covered in U.S. Vaccine market are:
Major players operating in the U.S. Vaccine Market include Sanofi Pasteur
GlaxoSmithKline Plc
Merck & Company Incorporated
Pfizer Incorporated
AstraZeneca plc
Boehringer Ingelheim
Bharat Biotech.
BIO-MED
Serum Institute of India Pvt. Ltd.
Kedrion Biopharma Inc. GlaxoSmithKline plc.
Bilthoven Biologicals
Cadila Healthcare Limited
Sanofi Pasteur India Pvt Ltd
Chiron Behring Vaccines Private Ltd
Zoetis Inc.
Elanco.
Boehringer Ingelheim International GmbH
Indian Immunologicals Ltd
Wyeth pharmaceuticals
Berna Biotech Ltd.
Novartis Vaccines Ltd
Medimmune LLC.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Vaccine Market by Type
4.1 U.S. Vaccine Market Snapshot and Growth Engine
4.2 U.S. Vaccine Market Overview
4.3 Human Vaccine (Pediatric Vaccines
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Human Vaccine (Pediatric Vaccines: Geographic Segmentation Analysis
4.4 Adult & Adolescent Vaccines
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Adult & Adolescent Vaccines: Geographic Segmentation Analysis
4.5 Other Human Vaccines
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Other Human Vaccines: Geographic Segmentation Analysis
Chapter 5: U.S. Vaccine Market by Application
5.1 U.S. Vaccine Market Snapshot and Growth Engine
5.2 U.S. Vaccine Market Overview
5.3 Livestock Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Livestock Vaccines: Geographic Segmentation Analysis
5.4 Companion Animal Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Companion Animal Vaccines: Geographic Segmentation Analysis
5.5 Other Animal Vaccines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Other Animal Vaccines: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MAJOR PLAYERS OPERATING IN THE U.S. VACCINE MARKET INCLUDE SANOFI PASTEUR
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 GLAXOSMITHKLINE PLC
6.4 MERCK & COMPANY INCORPORATED
6.5 PFIZER INCORPORATED
6.6 ASTRAZENECA PLC
6.7 BOEHRINGER INGELHEIM
6.8 BHARAT BIOTECH.
6.9 BIO-MED
6.10 SERUM INSTITUTE OF INDIA PVT. LTD.
6.11 KEDRION BIOPHARMA INC. GLAXOSMITHKLINE PLC.
6.12 BILTHOVEN BIOLOGICALS
6.13 CADILA HEALTHCARE LIMITED
6.14 SANOFI PASTEUR INDIA PVT LTD
6.15 CHIRON BEHRING VACCINES PRIVATE LTD
6.16 ZOETIS INC.
6.17 ELANCO.
6.18 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
6.19 INDIAN IMMUNOLOGICALS LTD
6.20 WYETH PHARMACEUTICALS
6.21 BERNA BIOTECH LTD.
6.22 NOVARTIS VACCINES LTD
6.23 AND MEDIMMUNE LLC.
Chapter 7: Global U.S. Vaccine Market By Region
7.1 Overview
7.2. North America U.S. Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Human Vaccine (Pediatric Vaccines
7.2.4.2 Adult & Adolescent Vaccines
7.2.4.3 Other Human Vaccines
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Livestock Vaccines
7.2.5.2 Companion Animal Vaccines
7.2.5.3 Other Animal Vaccines
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Human Vaccine (Pediatric Vaccines
7.3.4.2 Adult & Adolescent Vaccines
7.3.4.3 Other Human Vaccines
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Livestock Vaccines
7.3.5.2 Companion Animal Vaccines
7.3.5.3 Other Animal Vaccines
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Human Vaccine (Pediatric Vaccines
7.4.4.2 Adult & Adolescent Vaccines
7.4.4.3 Other Human Vaccines
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Livestock Vaccines
7.4.5.2 Companion Animal Vaccines
7.4.5.3 Other Animal Vaccines
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Human Vaccine (Pediatric Vaccines
7.5.4.2 Adult & Adolescent Vaccines
7.5.4.3 Other Human Vaccines
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Livestock Vaccines
7.5.5.2 Companion Animal Vaccines
7.5.5.3 Other Animal Vaccines
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Human Vaccine (Pediatric Vaccines
7.6.4.2 Adult & Adolescent Vaccines
7.6.4.3 Other Human Vaccines
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Livestock Vaccines
7.6.5.2 Companion Animal Vaccines
7.6.5.3 Other Animal Vaccines
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Human Vaccine (Pediatric Vaccines
7.7.4.2 Adult & Adolescent Vaccines
7.7.4.3 Other Human Vaccines
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Livestock Vaccines
7.7.5.2 Companion Animal Vaccines
7.7.5.3 Other Animal Vaccines
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Vaccine Scope:
|
Report Data
|
U.S. Vaccine Market
|
|
U.S. Vaccine Market Size in 2025
|
USD XX million
|
|
U.S. Vaccine CAGR 2025 - 2032
|
XX%
|
|
U.S. Vaccine Base Year
|
2024
|
|
U.S. Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Major players operating in the U.S. Vaccine Market include Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, Boehringer Ingelheim, Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd, Zoetis Inc., Elanco., Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd, and Medimmune LLC..
|
|
Key Segments
|
By Type
Human Vaccine (Pediatric Vaccines
Adult & Adolescent Vaccines
Other Human Vaccines
By Applications
Livestock Vaccines
Companion Animal Vaccines
Other Animal Vaccines
|
